RE: Next RNS30 Dec 2020 09:21
Bit from 3rd December rns and share price was around 16p
"A formulation stable at room temperature or even refrigerated can represent significant cost savings in vaccine transportation, storage and administration. We believe, to the extent that Nuvec® as a delivery platform can provide a solution in this area, it could be of significant interest to multiple vaccine developers.